Cellectar Biosciences Inc
CLRB2.760USD
+0.070+2.60%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
8.81MMarket Cap
LossP/E TTM
Cellectar Biosciences Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-36.52
65.22%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -36.520, with a year-on-year change of 65.22%.
What is the net income of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its net income was -44.58M, with a year-on-year change of -4.23%.
What is the net margin of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its Return on Equity (ROE) was -1402.33%, with a year-on-year change of -10.00%.
What is the Return on Assets (ROA) of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its Return on Assets (ROA) was -237.45%, with a year-on-year change of 6.55%.
What is the operating profit of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its operating profit was -51.78M, with a year-on-year change of -32.90%.
What are the current assets of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its current assets were 24.25M, with a year-on-year change of 131.99%.
What are the total assets of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its total assets of Cellectar Biosciences Inc were 25.47M, with a year-on-year change of 110.96%.
What are the total liabilities of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its total liabilities of Cellectar Biosciences Inc were 9.80M, with a year-on-year change of -27.06%.
What is the total equity of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its total equity of Cellectar Biosciences Inc was 15.68M, with a year-on-year change of 1256.06%.
What is the net operating income of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its net operating income of Cellectar Biosciences Inc was -44.58M, with a year-on-year change of -4.23%.
What is the net investment of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its net investment of Cellectar Biosciences Inc was -104.19K, with a year-on-year change of 87.94%.
What is the net financing of Cellectar Biosciences Inc?
According to Cellectar Biosciences Inc's FY2024 earnings report, its net financing of Cellectar Biosciences Inc was 61.41M, with a year-on-year change of 167.71%.
